← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2008Last known activity
Nov 4, 2019
Acquired by Lundbeck on Sep 16, 2019
Timeline
2000s
- Jun 1, 2004
Alder Biopharmaceuticals— Founded
2010s
- Sep 16, 2019
Lundbeck— Acquired By
Drugs by trial phase (9 distinct, 18 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (27)
- NCT04152083Lead sponsorPhase 3Nov 4, 2019
- NCT04197349CollaboratorN/ASep 24, 2019
- NCT02985398Lead sponsorPhase 3Dec 1, 2016
- NCT02985398Study directorPhase 3Dec 1, 2016
- NCT02974153Lead sponsorPhase 3Nov 1, 2016
- NCT02974153Study directorPhase 3Nov 1, 2016
- NCT02559895Study directorPhase 3Sep 1, 2015
- NCT02559895Lead sponsorPhase 3Sep 1, 2015
- NCT02275117Study directorPhase 2Oct 1, 2014
- NCT02275117Lead sponsorPhase 2Oct 1, 2014
- NCT02176655Reponsible party - principal investigatorPhase 2Jul 1, 2014
- NCT02015520Lead sponsorPhase 2Jan 1, 2014
- NCT01772524Study directorPhase 1Jan 1, 2013
- NCT01772524Lead sponsorPhase 1Jan 1, 2013
- NCT01545050Lead sponsorPhase 2Jun 1, 2012
Details
- Founded
- Bothell, WA, US Jun 1, 2004
- Last known activity
- Nov 4, 2019